Medical Condition News

RSS

Mayo Clinic investigators discover potential diagnostic markers for bipolar I disorder

Mayo Clinic researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication these markers may help as a diagnostic tool for psychiatrists treating mood disorders.

9 Dec 2015

Study emphasizes vital role of sleep in maintaining good emotional balance in our life

Cranky or grumpy after a long night? Your brain's ability to regulate emotions is probably compromised by fatigue. This is bad news for 30 percent of American adults who get less than six hours of sleep per night, according to the Centers for Disease Control and Prevention.

9 Dec 2015

UW named a final winner in Head Health Challenge II

Today, the University of Washington was named a final winner in the Head Health Challenge II, a collaboration among the NFL, Under Armour, and GE to identify and fund innovations that improve head health for athletes, members of the military and society at-large.

9 Dec 2015

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.

9 Dec 2015

New drug therapies that target glutamate pathway may be effective for subgroups of patient with schizophrenia

Mounting evidence indicates that disturbances in the brain's glutamate pathway contribute to symptoms of schizophrenia. Thus, the glutamate pathway has become the target of a number of new drug therapies. Findings published in the journal Biological Psychiatry suggest that at least one of these drugs may be an effective treatment for individuals in the early course of the illness.

9 Dec 2015

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Scientists at Oregon Research Institute have published unique research results indicating that a brief dissonance-based eating disorder prevention program (Body Project) alters how young women's brains respond to images of thin supermodels.

9 Dec 2015

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with the antiplatelet agent prasugrel does not significantly reduce the rate of pain crises or severe lung complications in children with sickle cell disease, according to a report published in the New England Journal of Medicine describing one of the largest and most geographically diverse international clinical trials on sickle cell disease to date.

9 Dec 2015

Lawson scientists develop commercial imaging product for PET/MRI scanners

Scientists at Lawson Health Research Institute, in collaboration with Ceresensa Inc., have produced the first commercial imaging product available in the world for PET/MRI scanners. The novel PET-transparent MRI head coil provides unparalleled images to advance the study, diagnosis and treatment of a wide range of diseases.

9 Dec 2015

Novel antidepressant appears to be safe, effective against depression in clinical trial

A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.

9 Dec 2015

Harvard's Kevin Staley honored with AES Research Recognition Award for Basic Science

The American Epilepsy Society announces that Kevin Staley, M.D., professor of child neurology and mental retardation at Harvard Medical School and chief of pediatric neurology at Massachusetts General Hospital, is being honored with the AES Research Recognition Award for Basic Science at the Society's 69th annual meeting in Philadelphia.

8 Dec 2015

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

Diacetyl, a flavoring chemical linked to cases of severe respiratory disease, was found in more than 75% of flavored electronic cigarettes and refill liquids tested by researchers at Harvard T.H. Chan School of Public Health.

8 Dec 2015

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

8 Dec 2015

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Australian drug development company Bionomics Limited will launch a key Phase 2 trial of its novel anxiety drug BNC210 as a treatment for post-traumatic stress disorder (PTSD), following a US$12 million private placement to US institutional investors.

8 Dec 2015

Kanuma approved as first treatment for patients with LAL deficiency

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

8 Dec 2015

Penn's Brian Litt recognized with AES Research Recognition Award for Clinical Science

The American Epilepsy Society announces that Brian Litt, M.D., professor of neurology, neurosurgery and bioengineering at the University of Pennsylvania, is being honored with the AES Research Recognition Award for Clinical Science on December 7, 2015, at the Society's 69th annual meeting in Philadelphia.

8 Dec 2015

BioLight announces first sale of IOPtiMate system in Portugal

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate system to a medical center located in Portugal.

8 Dec 2015

SRI Biosciences, SCI collaborate to develop novel compounds to treat multiple forms of cancer

A new collaborative program between scientists at SRI Biosciences, a division of SRI International, and physician-researchers from Stanford Cancer Institute will pursue development of novel compounds to treat multiple forms of cancer and other conditions.

8 Dec 2015

New way to antagonize human nuclear receptor

On Monday 7 December the journal Nature Communications published the research findings of Eindhoven University of Technology (TU/e), Merck Research Laboratories (Merck is known as MSD outside the US and Canada) and Leiden University concerning an entirely new way of antagonizing a human nuclear receptor.

8 Dec 2015

UB researchers develop a way to ramp up conversion of skin cells into dopamine neurons

For decades, the elusive holy grail in Parkinson's disease research has been finding a way to repair faulty dopamine neurons and put them back into patients, where they will start producing dopamine again. Researchers have used fetal material, which is difficult to obtain and of variable quality. Embryonic stem cells represented a tremendous innovation, but making dopamine neurons from stem cells is a long process with a low yield.

8 Dec 2015

NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test.

8 Dec 2015

Medical Condition News

Mayo Clinic investigators discover potential diagnostic markers for bipolar I disorder

Study emphasizes vital role of sleep in maintaining good emotional balance in our life

UW named a final winner in Head Health Challenge II

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

New drug therapies that target glutamate pathway may be effective for subgroups of patient with schizophrenia

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Lawson scientists develop commercial imaging product for PET/MRI scanners

Novel antidepressant appears to be safe, effective against depression in clinical trial

Harvard's Kevin Staley honored with AES Research Recognition Award for Basic Science

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Kanuma approved as first treatment for patients with LAL deficiency

Penn's Brian Litt recognized with AES Research Recognition Award for Clinical Science

BioLight announces first sale of IOPtiMate system in Portugal

SRI Biosciences, SCI collaborate to develop novel compounds to treat multiple forms of cancer

New way to antagonize human nuclear receptor

UB researchers develop a way to ramp up conversion of skin cells into dopamine neurons

NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News